Completing data — refresh the page later to see the latest
161696-76-0Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1FHPIXVHJEIZKJW-UHFFFAOYSA-N4'-N-desmethylolanzapine is a benzodiazepine.
161696-76-0DTXSID30433226Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (98.6%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 69 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesA metabolite of Olanzapine.
General DescriptionDesmethylolanzapine is the primary metabolite of olanzapine, marketed as the atypical antipsychotic Zyprexafor the treatment of schizophrenia and bipolar disorder. This new certified solution standard is suitable for use in LC or GC applications including clinical toxicology analysis, forensic testing, or therapeutic drug monitoring.
DefinitionChEBI: 4'-N-desmethylolanzapine is a benzodiazepine.
CHEMBL1125CHEBI:168745